相关实验视频

Updated: May 12, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

转移性三阴性乳腺癌中的sacituzumab-govitecan:一个多中心的有效性和安全性研究

Isabel María Carrión-Madroñal¹, Rocío Díaz-Acedo², Santiago José Lora-Escobar²

¹Servicio de Farmacia, Hospital Universitario Virgen Macarena, Seville, 41009, SPAIN.

Future oncology (London, England)

|September 12, 2024

概括

萨西图祖马布-戈维特坎 (Sgov) 在转移性三阴性乳腺癌 (mTNBC) 现实世界数据中显示了可接受的安全性. 然而,有效性可能低于预期,特别是在性能状况较差的患者中.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
临床试验临床试验

背景情况:

萨西图祖马布-戈维特肯 (Sgov) 是一种已批准用于转移性三阴性乳腺癌 (mTNBC) 的抗体-药物结合物.
对于mTNBC患者中的Sgov,现实世界数据有限.
关键的ASCENT试验为Sgov的疗效和安全提供了一个基准.

研究的目的:

评估Sgov在mTNBC患者中的实际有效性和安全性.
将Sgov在现实环境中的结果与ASCENT试验结果进行比较.
确定可能从Sgov治疗中受益较少的患者子组.

主要方法:

在三家主要医院对46名mTNBC患者接受Sgov治疗的回顾性分析.
数据收集包括患者人口统计,东部合作瘤学集团 (ECOG) 绩效状况和治疗结果.
将现实世界的数据与ASCENT试验的发现进行比较.

主要成果:

在现实世界中,Sgov的有效性似乎略低于从临床试验中预期的.
具有2或更高ECOG绩效状态的患者显示Sgov.gov的益处显著减少.
在这个患者队列中,Sgov的安全性被认为是可以接受的.

结论:

Sgov在现实世界mTNBC治疗中展示了可接受的安全性.
现实世界的有效性可能与关键试验数据不完全一致,特别是在具有性能状况受损的患者中.
需要对mTNBC中Sgov的患者选择和治疗优化进行进一步的研究.

关键词:

有效性有效性.转移的三阴性乳腺癌.现实世界的数据数据.萨西图祖马布-戈维特可以在安全方面,安全是安全的.

更多相关视频

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...